Evidence map›Paper›PMID 37005433›Full record

ArticleACS chemical biology2023

Pseudouridine-Modifying Enzymes SapB and SapH Control Entry into the Pseudouridimycin Biosynthetic Pathway.

Erika Artukka, Robert Schnell, Kaisa Palmu, Petja Rosenqvist, Edit Szodorai, Jarmo Niemi, Pasi Virta, Gunter Schneider, Mikko Metsä-Ketelä

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS chemical biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Biosynthesis and Genome Mining Potentials of Nucleoside Natural Products.Chembiochem : a European journal of chemical biology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Erika ArtukkaDepartment of Life Technologies, University of Turku, FIN-20014 Turku, Finland.
Robert SchnellDepartment of Neuroscience, Karolinska Institutet, SE-17177 Stockholm, Sweden.
Kaisa PalmuDepartment of Life Technologies, University of Turku, FIN-20014 Turku, Finland.
Petja RosenqvistDepartment of Chemistry, University of Turku, FIN-20014 Turku, Finland.
Edit SzodoraiDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-17177 Stockholm, Sweden.
Jarmo NiemiDepartment of Life Technologies, University of Turku, FIN-20014 Turku, Finland.ORCID 0000-0002-7447-8379
Pasi VirtaDepartment of Chemistry, University of Turku, FIN-20014 Turku, Finland.ORCID 0000-0002-6218-2212
Gunter SchneiderDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-17177 Stockholm, Sweden.
Mikko Metsä-KeteläDepartment of Life Technologies, University of Turku, FIN-20014 Turku, Finland.ORCID 0000-0003-3176-2908
University of Turku · FIKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudouridimycin is a microbial

Indexed as

NucleosidesPseudouridineBacterial ProteinsBiosynthetic PathwaysDNA-Directed RNA PolymerasesPyridoxal PhosphateStreptomycesUridineBacterial ProteinsDNA-Directed RNA PolymerasesminimycinNucleosidespseudouridimycinPseudouridinePyridoxal PhosphateStreptomyces spore-associated proteinsUridine

Identifiers

PMID37005433
PMCPMC10127198
OpenAlexW4362506329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.